A 34-year-old woman comes to the clinic for a 6-week follow-up visit. She was diagnosed wi… — USMLE Step 2 CK

A $34$ -year-old woman comes to the clinic for a $6$ -week follow-up visit. She was diagnosed with Graves disease after presenting with a $4$ -kg ( $8.8$ -lb) weight loss, frequent palpitations, and heat intolerance. At the time of diagnosis, her thyroid-stimulating hormone (TSH) level was $<0.01$ $\mu$ U/mL and her free thyroxine (T4) level was $3.8$ ng/dL. She was initiated on methimazole and propranolol. Today, the patient reports that she feels much better; her palpitations have resolved, she is sleeping well, and her weight has remained stable for the past three weeks. Vital signs are temperature $37.0^\circ\text{C}$ ( $98.6^\circ\text{F}$ ), blood pressure $118/74$ mm Hg, and pulse $72$ /min. Physical examination shows a mild, non-tender thyromegaly. She has no tremors. Laboratory evaluation today shows:

Test	Patient Result	Reference Range
TSH	$<0.01$ $\mu$ U/mL	$0.5 - 5.0$ $\mu$ U/mL
Free T4	$1.3$ ng/dL	$0.9 - 1.7$ ng/dL
Total T3	$120$ ng/dL	$80 - 200$ ng/dL

Which of the following is the most appropriate next step in management?

Continue the current methimazole dosageAnswer
B
Increase the methimazole dosage
C
Switch to radioactive iodine ablation
D
Add levothyroxine to the current regimen
E
Discontinue methimazole

Answer

Continue the current methimazole dosage

The correct answer is to continue the current methimazole dosage. This patient has achieved clinical euthyroidism (resolution of symptoms, normal heart rate) and biochemical euthyroidism (normalized Free T4 and Total T3) on her current regimen. In the initial months of treating overt hyperthyroidism, the pituitary thyrotrophs remain functionally suppressed due to prolonged prior exposure to high circulating thyroid hormone levels. As a result, TSH levels typically remain low for several months and do not accurately reflect the patient's current metabolic state. During this 'pituitary lag' phase, antithyroid drug dosages must be titrated strictly based on Free T4 and Total T3 levels. Because her peripheral thyroid hormones are well within the normal limits, continuing the current dosage is the most appropriate next step.

Step-by-Step Solution

Assess the patient's clinical status.

Symptoms have resolved, weight is stable, and heart rate is normal.

Clinical presentation guides the interpretation of laboratory values and confirms a positive response to therapy.

Evaluate the current thyroid hormone levels.

Free T4 and Total T3 have normalized, but TSH remains suppressed (<0.01 μU/mL).

To determine the biochemical response to the initial methimazole therapy after 6 weeks.

Interpret the discordant laboratory findings.

The suppressed TSH represents a normal physiologic lag in pituitary thyrotroph recovery following prolonged hyperthyroidism, not treatment failure.

TSH can remain suppressed for 3-6 months and is not reliable for early dose titration in hyperthyroidism.

Determine the next step in management.

The current methimazole dosage should be maintained.

The patient is biochemically and clinically euthyroid based on Free T4/T3 levels, requiring no antithyroid dose adjustment at this time.

Key Concept

During the first few months of treating hyperthyroidism, TSH levels remain suppressed due to a physiological lag in pituitary recovery. Antithyroid drug dosages must be titrated based on Free T4 and Total T3 levels rather than TSH.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic